4.7 Article

Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 909, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.ejphar.2021.174398

关键词

CB2 receptor agonists; JWH133; Synthetic cannabinoids; Neuroprotective; Neuroprotection; Neurodegeneration; Neuroinflammation

资金

  1. United Arab Emirates University, United Arab Emirates
  2. ADEK award for Research Excellence (AARE) [AARE18-194]

向作者/读者索取更多资源

The pharmacological activation of CB2R, particularly by the compound JWH133, has shown promising neuroprotective and anti-inflammatory effects in various neurological disorders, making it a potential candidate for drug development in neurotherapeutics. Further regulatory toxicology and pharmacokinetic studies are needed to evaluate its safety for clinical use.
The pharmacological activation of cannabinoid type 2 receptors (CB2R) gained attention due to its ability to mitigate neuroinflammatory events without eliciting psychotropic actions, a limiting factor for the drugs tar-geting cannabinoid type 1 receptors (CB1R). Therefore, ligands activating CB2R are receiving enormous importance for therapeutic targeting in numerous neurological diseases including neurodegenerative, neuro-psychiatric and neurodevelopmental disorders as well as traumatic injuries and neuropathic pain where neu-roinflammation is a common accompaniment. Since the characterization of CB2R, many CB2R selective synthetic ligands have been developed with high selectivity and functional activity. Among numerous ligands, JWH133 has been found one of the compounds with high selectivity for CB2R. JWH133 has been reported to exhibit numerous pharmacological activities including antioxidant, anti-inflammatory, anticancer, cardioprotective, hepatoprotective, gastroprotective, nephroprotective, and immunomodulatory. Recent studies have shown that JWH133 possesses potent neuroprotective properties in several neurological disorders, including neuropathic pain, anxiety, epilepsy, depression, alcoholism, psychosis, stroke, and neurodegeneration. Additionally, JWH133 showed to protect neurons from oxidative damage and inflammation, promote neuronal survival and neuro-genesis, and serve as an immunomodulatory agent. The present review comprehensively examined neurophar-macological activities of JWH133 in neurological disorders including neurodegenerative, neurodevelopmental and neuropsychiatric using synoptic tables and elucidated pharmacological mechanisms based on reported ob-servations. Considering the cumulative data, JWH133 appears to be a promising CB2R agonist molecule for further evaluation and it can be a prototype agent in drug discovery and development for a unique class of agents in neurotherapeutics. Further, regulatory toxicology and pharmacokinetic studies are required to determine safety and proceed for clinical evaluation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据